Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000513446 | SCV000608551 | uncertain significance | not provided | 2017-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088093 | SCV001107446 | benign | Sphingolipid activator protein 1 deficiency | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023457 | SCV005012011 | likely benign | Inborn genetic diseases | 2022-12-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001829458 | SCV002087097 | benign | Metachromatic leukodystrophy | 2020-01-16 | no assertion criteria provided | clinical testing |